- Home
- LW vs CORT Comparison
LW vs CORT Comparison
Compare LW & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LW | CORT |
|---|---|---|
| Founded | 1950 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 7.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LW | CORT |
|---|---|---|
| Price | $59.43 | $82.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $66.00 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 1.1M | 821.3K |
| Earning Date | 12-19-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.08 | 0.87 |
| Revenue | ★ $6,456,500,000.00 | $741,172,000.00 |
| Revenue This Year | $4.12 | $23.79 |
| Revenue Next Year | N/A | $40.97 |
| P/E Ratio | ★ $28.79 | $92.87 |
| Revenue Growth | 0.00 | ★ 17.92 |
| 52 Week Low | $47.87 | $49.00 |
| 52 Week High | $83.98 | $117.33 |
Technical Indicators
Market Signals| Indicator | LW | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 49.74 | 51.62 |
| Support Level | $59.20 | $78.07 |
| Resistance Level | $60.41 | $89.00 |
| Average True Range (ATR) | 1.27 | 3.40 |
| MACD | 0.18 | -0.11 |
| Stochastic Oscillator | 60.75 | 39.42 |
Price Performance
Historical ComparisonAbout LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.